1. Home
  2. OSPN vs CGEM Comparison

OSPN vs CGEM Comparison

Compare OSPN & CGEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSPN
  • CGEM
  • Stock Information
  • Founded
  • OSPN 1991
  • CGEM 2016
  • Country
  • OSPN United States
  • CGEM United States
  • Employees
  • OSPN N/A
  • CGEM N/A
  • Industry
  • OSPN EDP Services
  • CGEM Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSPN Technology
  • CGEM Health Care
  • Exchange
  • OSPN Nasdaq
  • CGEM Nasdaq
  • Market Cap
  • OSPN 688.4M
  • CGEM 730.2M
  • IPO Year
  • OSPN 1998
  • CGEM 2021
  • Fundamental
  • Price
  • OSPN $18.25
  • CGEM $11.63
  • Analyst Decision
  • OSPN Strong Buy
  • CGEM Strong Buy
  • Analyst Count
  • OSPN 5
  • CGEM 7
  • Target Price
  • OSPN $16.50
  • CGEM $31.67
  • AVG Volume (30 Days)
  • OSPN 436.0K
  • CGEM 533.4K
  • Earning Date
  • OSPN 10-30-2024
  • CGEM 11-07-2024
  • Dividend Yield
  • OSPN N/A
  • CGEM N/A
  • EPS Growth
  • OSPN N/A
  • CGEM N/A
  • EPS
  • OSPN 0.75
  • CGEM N/A
  • Revenue
  • OSPN $244,936,000.00
  • CGEM N/A
  • Revenue This Year
  • OSPN $4.28
  • CGEM N/A
  • Revenue Next Year
  • OSPN $3.43
  • CGEM N/A
  • P/E Ratio
  • OSPN $24.49
  • CGEM N/A
  • Revenue Growth
  • OSPN 7.05
  • CGEM N/A
  • 52 Week Low
  • OSPN $9.22
  • CGEM $9.24
  • 52 Week High
  • OSPN $19.58
  • CGEM $30.19
  • Technical
  • Relative Strength Index (RSI)
  • OSPN 51.55
  • CGEM 37.71
  • Support Level
  • OSPN $17.84
  • CGEM $10.44
  • Resistance Level
  • OSPN $19.58
  • CGEM $12.79
  • Average True Range (ATR)
  • OSPN 0.75
  • CGEM 0.68
  • MACD
  • OSPN -0.15
  • CGEM -0.03
  • Stochastic Oscillator
  • OSPN 35.44
  • CGEM 35.53

About OSPN OneSpan Inc.

OneSpan Inc is a provider of information technology security solutions for banking and financial services and application security markets. Its solutions secure and manage access to digital assets and protect online transactions, via mobile devices and in-person. Authentication and anti-fraud solutions are the organization's primary product offerings and include multifactor authentication and virtual private network access capabilities. The company derives revenues from hardware and license fees, maintenance and support fees, and subscription fees. A large majority of the firm's revenue is generated in Europe, the Middle East, and Africa, and the rest in the United States and Asia-Pacific region.

About CGEM Cullinan Oncology Inc.

Cullinan Therapeutics Inc is a biopharmaceutical company. It has diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, create differentiated ideas, identify the appropriate targets, and select the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications.

Share on Social Networks: